BiotechTube
XingImaging

XingImaging

Cambridge, United States· Est.
xingimaging.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

XingImaging, founded in 2018 and based in Cambridge, Massachusetts, with a major operational facility in New Haven, Connecticut, is a specialized neuroimaging services provider. The company leverages scintigraphic imaging (e.g., PET, SPECT) and radiopharmaceutical expertise to support biopharma clients in developing and validating biomarkers for central nervous system disorders. Its integrated model spans radioligand manufacturing, clinical trial design, and multi-site imaging coordination, positioning it as a critical partner in the translational neuroscience space. As a subsidiary of MITRO, it benefits from corporate backing while operating with a focused team of over 40 staff.

Neurodegenerative DisordersNeuropsychiatric Disorders

Technology Platform

Integrated scintigraphic imaging services platform encompassing radioligand development/manufacturing, quantitative PET/SPECT imaging analysis, and multi-site clinical trial imaging coordination.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing emphasis on biomarkers in CNS drug development, accelerated by recent Alzheimer's disease therapy approvals, creates strong demand for specialized imaging services.
Expansion into new biomarker targets (e.g., alpha-synuclein, TDP-43) and offering integrated data packages with AI-driven image analysis present significant growth avenues.

Risk Factors

Revenue is highly dependent on the fluctuating R&D budgets of a limited number of biopharma clients.
The operational complexity of handling radioactive materials and coordinating multi-site trials introduces significant regulatory and execution risks that could impact reputation and financials.

Competitive Landscape

XingImaging competes with imaging divisions of large, full-service CROs (e.g., ICON, Parexel), academic core labs, and other specialized neuroimaging CROs. Its differentiation lies in its deep, integrated focus on neuroscience, in-house radiochemistry capabilities, and operational expertise with investigational radiotracers.

More companies in United States →